Elevated levels of Von Willebrand factor (VWF), fibrinogen, and the fibrin degradation product D-dimer, along with a mildly prolonged prothrombin time (PT) and thromboelastographic data that indicates clot stability, all support a COVID-19 specific coagulopathy hypothesis5–8. Here, VWF is linked to COVID-19.